Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:developedBy |
gptkb:Relay_Therapeutics
|
| gptkbp:indication |
cholangiocarcinoma
solid tumors with FGFR2 alterations |
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
FGFR2 inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:FGFR2
|
| gptkbp:bfsParent |
gptkb:Relay_Therapeutics
|
| gptkbp:bfsLayer |
6
|
| http://www.w3.org/2000/01/rdf-schema#label |
RLY-4008
|